Meta-analyses of the association between cytochrome CYP2C19 loss-and gain-of-function polymorphisms and cardiovascular outcomes in patients with coronary …

M Zabalza, I Subirana, J Sala, C Lluis-Ganella… - Heart, 2012 - heart.bmj.com
Aims To perform a meta-analysis of the association between CYP2C19 loss-and gain-of-
function variants and cardiovascular outcomes and bleeding in patients with coronary artery …
被引用次数：210 相关文章
[PDF] redheracles.net

[PDF][PDF] Meta-analyses of the association between cytochrome CYP2C19 loss-and gain-of-function polymorphisms and cardiovascular outcomes in patients with …

M Zabalza, I Subirana, J Sala, C Lluis-Ganella… - Heart, 2012 - redheracles.net
Aims To perform a meta-analysis of the association between CYP2C19 loss-and gain-of-
function variants and cardiovascular outcomes and bleeding in patients with coronary artery …

Meta-analyses of the association between cytochrome CYP2C19 loss-and gain-of-function polymorphisms and cardiovascular outcomes in patients with coronary …

M Zabalza, I Subirana, J Sala… - Heart (British Cardiac …, 2011 - europepmc.org
Aims To perform a meta-analysis of the association between CYP2C19 loss-and gain-of-
function variants and cardiovascular outcomes and bleeding in patients with coronary artery …

Meta-analyses of the association between cytochrome CYP2C19 loss-and gain-of-function polymorphisms and cardiovascular outcomes in patients with coronary …

M Zabalza, I Subirana, J Sala… - Heart (British …, 2012 - pubmed.ncbi.nlm.nih.gov
Aims To perform a meta-analysis of the association between CYP2C19 loss-and gain-of-
function variants and cardiovascular outcomes and bleeding in patients with coronary artery …

[引用][C] Meta-analyses of the association between cytochrome CYP2C19 loss-and gain-of-function polymorphisms and cardiovascular outcomes in patients with …

M Zabalza, I Subirana, J Sala, C Lluis-Ganella… - Heart, 2011 - cir.nii.ac.jp
Meta-analyses of the association between cytochrome CYP2C19 loss- and gain-of-function
polymorphisms and cardiovascular outcomes in patients with coronary artery disease treated …

Meta-analyses of the association between cytochrome CYP2C19 loss-and gain-of-function polymorphisms and cardiovascular outcomes in patients with coronary …

M Zabalza, I Subirana, J Sala, C Lluis-Ganella… - Heart, 2012 - search.proquest.com
Aims To perform a meta-analysis of the association between CYP2C19 loss-and gain-of-
function variants and cardiovascular outcomes and bleeding in patients with coronary artery …
[PDF] redheracles.net

[PDF][PDF] Meta-analyses of the association between cytochrome CYP2C19 loss-and gain-of-function polymorphisms and cardiovascular outcomes in patients with …

M Zabalza, I Subirana, J Sala, C Lluis-Ganella… - Heart, 2012 - redheracles.net
Aims To perform a meta-analysis of the association between CYP2C19 loss-and gain-of-
function variants and cardiovascular outcomes and bleeding in patients with coronary artery …

Meta-analyses of the association between cytochrome CYP2C19 loss-and gain-of-function polymorphisms and cardiovascular outcomes in patients with coronary …

M Zabalza, I Subirana, J Sala, C Lluis-Ganella… - Heart, 2011 - heart.bmj.com
Aims To perform a meta-analysis of the association between CYP2C19 loss-and gain-of-
function variants and cardiovascular outcomes and bleeding in patients with coronary artery …
[PDF] archive.org

[PDF][PDF] Meta-analyses of the association between cytochrome CYP2C19 loss-and gain-of-function polymorphisms and cardiovascular outcomes in patients with …

M Zabalza, I Subirana, J Sala, C Lluis-Ganella… - Heart, 2012 - scholar.archive.org
Aims To perform a meta-analysis of the association between CYP2C19 loss-and gain-of-
function variants and cardiovascular outcomes and bleeding in patients with coronary artery …

[引用][C] Meta-analyses of the association between cytochrome CYP2C19 loss-and gain-of-function polymorphisms and cardiovascular outcomes in patients with …

M ZABALZA, I SUBIRANA, J SALA… - Heart (London …, 2012 - pascal-francis.inist.fr
Meta-analyses of the association between cytochrome CYP2C19 loss- and gain-of-function
polymorphisms and cardiovascular outcomes in patients with coronary artery disease …